JP2018513188A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018513188A5 JP2018513188A5 JP2017555494A JP2017555494A JP2018513188A5 JP 2018513188 A5 JP2018513188 A5 JP 2018513188A5 JP 2017555494 A JP2017555494 A JP 2017555494A JP 2017555494 A JP2017555494 A JP 2017555494A JP 2018513188 A5 JP2018513188 A5 JP 2018513188A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- meropenem
- pharmaceutically acceptable
- acceptable salt
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 17
- 150000001875 compounds Chemical class 0.000 claims 16
- DMJNNHOOLUXYBV-PQTSNVLCSA-N meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 claims 13
- 229960002260 meropenem Drugs 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 13
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims 8
- 229940000425 combination drug Drugs 0.000 claims 4
- 229940109239 creatinine Drugs 0.000 claims 4
- 208000035143 Bacterial infection Diseases 0.000 claims 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims 3
- 238000001802 infusion Methods 0.000 claims 3
- 238000001990 intravenous administration Methods 0.000 claims 3
- 241000588921 Enterobacteriaceae Species 0.000 claims 1
- 206010024971 Lower respiratory tract infections Diseases 0.000 claims 1
- 206010062237 Renal impairment Diseases 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000000043 antiallergic agent Substances 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 231100000857 poor renal function Toxicity 0.000 claims 1
- IOOWNWLVCOUUEX-WPRPVWTQSA-N OB1O[C@H](CC(O)=O)CC[C@@H]1NC(Cc1ccc[s]1)=O Chemical compound OB1O[C@H](CC(O)=O)CC[C@@H]1NC(Cc1ccc[s]1)=O IOOWNWLVCOUUEX-WPRPVWTQSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021101472A JP7245289B2 (ja) | 2015-04-24 | 2021-06-18 | 細菌感染症の処置方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562152668P | 2015-04-24 | 2015-04-24 | |
| US62/152,668 | 2015-04-24 | ||
| PCT/US2016/028437 WO2016172208A1 (en) | 2015-04-24 | 2016-04-20 | Methods of treating bacterial infections |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021101472A Division JP7245289B2 (ja) | 2015-04-24 | 2021-06-18 | 細菌感染症の処置方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018513188A JP2018513188A (ja) | 2018-05-24 |
| JP2018513188A5 true JP2018513188A5 (enExample) | 2019-05-30 |
| JP6945452B2 JP6945452B2 (ja) | 2021-10-06 |
Family
ID=57144340
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555494A Active JP6945452B2 (ja) | 2015-04-24 | 2016-04-20 | 細菌感染症の処置方法 |
| JP2021101472A Active JP7245289B2 (ja) | 2015-04-24 | 2021-06-18 | 細菌感染症の処置方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021101472A Active JP7245289B2 (ja) | 2015-04-24 | 2021-06-18 | 細菌感染症の処置方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20160339045A1 (enExample) |
| EP (1) | EP3285776B1 (enExample) |
| JP (2) | JP6945452B2 (enExample) |
| CN (2) | CN107530364A (enExample) |
| AU (1) | AU2016252555A1 (enExample) |
| CA (1) | CA2982911C (enExample) |
| ES (1) | ES2942329T3 (enExample) |
| WO (1) | WO2016172208A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2599791C2 (ru) | 2010-08-10 | 2016-10-20 | Ремпекс Фармасьютикэлз, Инч. | Циклические бороновые кислотно-эфирные производные и их использование в терапии |
| AU2014204045B2 (en) | 2013-01-04 | 2018-10-18 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| WO2015171398A1 (en) | 2014-05-05 | 2015-11-12 | Rempex Pharmaceuticals, Inc. | Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof |
| RS59488B1 (sr) | 2014-05-05 | 2019-12-31 | Rempex Pharmaceuticals Inc | Sinteza boronatnih soli i njihove upotrebe |
| JP6672176B2 (ja) | 2014-05-19 | 2020-03-25 | レンペックス・ファーマシューティカルズ・インコーポレイテッド | ボロン酸誘導体およびその治療的使用 |
| AU2015284307A1 (en) | 2014-07-01 | 2017-02-02 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| US10662205B2 (en) | 2014-11-18 | 2020-05-26 | Qpex Biopharma, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| US20180051041A1 (en) | 2015-03-17 | 2018-02-22 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| JP7060245B2 (ja) | 2016-06-30 | 2022-04-26 | キューペックス バイオファーマ， インコーポレイテッド | ボロン酸誘導体およびその治療的使用 |
| PT3565551T (pt) * | 2017-01-09 | 2024-06-14 | Melinta Therapeutics Inc | Métodos de tratamento de infeções bacterianas com uma combinação de vaborbactam e meropenem |
| AU2018345317B2 (en) * | 2017-10-03 | 2024-10-24 | Melinta Therapeutics, Inc. | Methods of treating bacterial infections |
| CA3078627A1 (en) | 2017-10-11 | 2019-04-18 | Qpex Biopharma, Inc. | Boronic acid derivatives and synthesis thereof |
| EP3781576B1 (en) | 2018-04-20 | 2024-06-12 | Qpex Biopharma, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| CN116098993B (zh) * | 2022-11-17 | 2024-10-25 | 中国农业科学院特产研究所 | 一种狐、貉肺炎三联灭活疫苗及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783443A (en) | 1986-03-03 | 1988-11-08 | The University Of Chicago | Amino acyl cephalosporin derivatives |
| RU2599791C2 (ru) | 2010-08-10 | 2016-10-20 | Ремпекс Фармасьютикэлз, Инч. | Циклические бороновые кислотно-эфирные производные и их использование в терапии |
| US10561675B2 (en) * | 2012-06-06 | 2020-02-18 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
-
2016
- 2016-04-20 US US15/134,198 patent/US20160339045A1/en not_active Abandoned
- 2016-04-20 EP EP16783764.0A patent/EP3285776B1/en active Active
- 2016-04-20 JP JP2017555494A patent/JP6945452B2/ja active Active
- 2016-04-20 WO PCT/US2016/028437 patent/WO2016172208A1/en not_active Ceased
- 2016-04-20 ES ES16783764T patent/ES2942329T3/es active Active
- 2016-04-20 CN CN201680023884.XA patent/CN107530364A/zh active Pending
- 2016-04-20 CA CA2982911A patent/CA2982911C/en active Active
- 2016-04-20 AU AU2016252555A patent/AU2016252555A1/en not_active Abandoned
- 2016-04-20 CN CN202110100198.0A patent/CN112755039A/zh active Pending
-
2018
- 2018-07-06 US US16/029,388 patent/US20190105337A1/en not_active Abandoned
-
2021
- 2021-06-18 JP JP2021101472A patent/JP7245289B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018513188A5 (enExample) | ||
| Douafer et al. | Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases | |
| JP2011173928A5 (enExample) | ||
| JP2005520778A5 (enExample) | ||
| RU2010140682A (ru) | Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство | |
| JP2019517542A5 (enExample) | ||
| CN111902417A (zh) | 一种二芳基巨环化合物、药物组合物以及其用途 | |
| JP2019524865A5 (enExample) | ||
| JP2016185995A5 (enExample) | ||
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2009529502A5 (enExample) | ||
| CN107519159A (zh) | 复方组合物 | |
| JP2011503044A5 (enExample) | ||
| RU2014141893A (ru) | Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких | |
| JP2013518124A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| JP2020515523A5 (enExample) | ||
| JP2014148552A5 (enExample) | ||
| JP2020510043A5 (enExample) | ||
| MX2018013475A (es) | Acido carboxilico para tratar/prevenir congestion nasal. | |
| CN107714678B (zh) | 紫檀芪在制备mcr-1酶抑制剂中的应用 | |
| JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 | |
| JP2019535830A5 (enExample) | ||
| CN108472375A (zh) | 中重度流感的治疗方法 | |
| US20050227949A1 (en) | Compositions and methods for treatment of viral and bacterial infections |